Breaking News, Financial News

Financial Report: AmerisourceBergen

Revenues up 28% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AmerisourceBergen 4Q Revenues: $24.5 billion (+28%) 4Q Earnings: $51.0 million (-69%) FY Revenues: $88.0 billion (+13%) FY Earnings: $433.7 million (-40%) Comments: Growth in the quarter reflects a 34% increase in AmerisourceBergen Drug Corp. (ABDC) revenue, and a 12% increase in AmerisourceBergen Specialty Group (ABSG) revenue. Pharmaceutical Distribution revenues were $24.1 billion, up 29%. Earnings reflect discontinued operations from AndersonBrecon and AmerisourceBergen Canada Corp., bo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters